Exenatide vs Brenipatide
A GLP-1 receptor agonist derived from Gila monster venom (exendin-4). A once-monthly dual GIP/GLP-1 agonist aimed at the brain's reward circuitry rather than the scale. Side by side: type, evidence tier, receptor, molecular weight, and half-life — the same fields as each monograph, rearranged so the engineering difference is visible.
Exenatide | Brenipatide LY3537031 | |
|---|---|---|
| Also known as | Byetta, Bydureon | — |
| Type | Analog | Analog |
| Evidence | Established | Investigational |
| Family | Incretins & metabolic | Incretins & metabolic |
| Class | GLP-1 receptor agonist (exendin-4, 39 aa) | GIP/GLP-1 dual agonist (acylated peptide) |
| Receptor | GLP-1 receptor (GLP-1R) | GIP + GLP-1 receptors |
| Molecular weight | ~4,186.6 Da | ≈4,900 Da |
| Half-life | engineered for once-monthly dosing | |
| Based on | Glucagon-like peptide-1 | Glucagon-like peptide-1 |
Half-life bars are on a logarithmic scale across the molecules shown. Reference values for the native or representative form — educational only, not medical or dosing advice.
Common questions
- What is the difference between Exenatide and Brenipatide?
- Exenatide is an engineered analog based on Glucagon-like peptide-1; Brenipatide is an engineered analog based on Glucagon-like peptide-1. Exenatide signals at GLP-1 receptor (GLP-1R); Brenipatide signals at GIP + GLP-1 receptors.
- How do the half-lives of Exenatide and LY3537031 compare?
- The reported circulating half-life of Exenatide is ~2.4 h (immediate-release); Brenipatide is engineered for once-monthly dosing. These are reference values for the native or representative form — educational only, not dosing advice.
- Is Exenatide the same as Byetta?
- Byetta, Bydureon are brand names of Exenatide. This comparison describes the molecules, not branded products.
Prefer the other order? Brenipatide vs Exenatide. Or open the interactive comparison tool to add more molecules.